Chemotherapy and immunotherapy: mapping the road ahead
Author:
Publisher
Elsevier BV
Subject
Immunology,Immunology and Allergy
Reference55 articles.
1. Breakthrough of the year 2013. Cancer immunotherapy;Couzin-Frankel;Science,2013
2. Cancer and the immune system: basic concepts and targets for intervention;Pardoll;Semin Oncol,2015
3. Caspase-dependent immunogenicity of doxorubicin-induced tumor cell death;Casares;J Exp Med,2005
4. Consensus guidelines for the detection of immunogenic cell death;Kepp;Oncoimmunology,2014
5. Immunogenic cell death and DAMPs in cancer therapy;Krysko;Nat Rev Cancer,2012
Cited by 105 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Revamping precision treatment with nanoparticles envisaging effective drug delivery systems for ovarian cancer;Process Biochemistry;2024-03
2. A natural product-derived nanozyme regulator induced chemo-ferroptosis dual therapy in remodeling of the tumor immune microenvironment of hepatocellular carcinoma;Chemical Engineering Journal;2024-02
3. Construction of quercetin-fucoidan nanoparticles and their application in cancer chemo-immunotherapy treatment;International Journal of Biological Macromolecules;2024-01
4. Multifunctional nanocomposites modulating the tumor microenvironment for enhanced cancer immunotherapy;Bioactive Materials;2024-01
5. Therapeutic supramolecular polymers: Designs and applications;Progress in Polymer Science;2024-01
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3